227 related articles for article (PubMed ID: 29567411)
1. Abnormal nuclear morphology is independent of longevity in a zmpste24-deficient fish model of Hutchinson-Gilford progeria syndrome (HGPS).
Tonoyama Y; Shinya M; Toyoda A; Kitano T; Oga A; Nishimaki T; Katsumura T; Oota H; Wan MT; Yip BWP; Helen MOL; Chisada S; Deguchi T; Au DWT; Naruse K; Kamei Y; Taniguchi Y
Comp Biochem Physiol C Toxicol Pharmacol; 2018 Jul; 209():54-62. PubMed ID: 29567411
[TBL] [Abstract][Full Text] [Related]
2. Blocking protein farnesyltransferase improves nuclear shape in fibroblasts from humans with progeroid syndromes.
Toth JI; Yang SH; Qiao X; Beigneux AP; Gelb MH; Moulson CL; Miner JH; Young SG; Fong LG
Proc Natl Acad Sci U S A; 2005 Sep; 102(36):12873-8. PubMed ID: 16129834
[TBL] [Abstract][Full Text] [Related]
3. Inhibiting farnesylation reverses the nuclear morphology defect in a HeLa cell model for Hutchinson-Gilford progeria syndrome.
Mallampalli MP; Huyer G; Bendale P; Gelb MH; Michaelis S
Proc Natl Acad Sci U S A; 2005 Oct; 102(40):14416-21. PubMed ID: 16186497
[TBL] [Abstract][Full Text] [Related]
4. Heterozygosity for Lmna deficiency eliminates the progeria-like phenotypes in Zmpste24-deficient mice.
Fong LG; Ng JK; Meta M; Coté N; Yang SH; Stewart CL; Sullivan T; Burghardt A; Majumdar S; Reue K; Bergo MO; Young SG
Proc Natl Acad Sci U S A; 2004 Dec; 101(52):18111-6. PubMed ID: 15608054
[TBL] [Abstract][Full Text] [Related]
5. A homozygous ZMPSTE24 null mutation in combination with a heterozygous mutation in the LMNA gene causes Hutchinson-Gilford progeria syndrome (HGPS): insights into the pathophysiology of HGPS.
Denecke J; Brune T; Feldhaus T; Robenek H; Kranz C; Auchus RJ; Agarwal AK; Marquardt T
Hum Mutat; 2006 Jun; 27(6):524-31. PubMed ID: 16671095
[TBL] [Abstract][Full Text] [Related]
6. Abolishing the prelamin A ZMPSTE24 cleavage site leads to progeroid phenotypes with near-normal longevity in mice.
Wang Y; Shilagardi K; Hsu T; Odinammadu KO; Maruyama T; Wu W; Lin CS; Damoci CB; Spear ED; Shin JY; Hsu W; Michaelis S; Worman HJ
Proc Natl Acad Sci U S A; 2022 Mar; 119(9):. PubMed ID: 35197292
[TBL] [Abstract][Full Text] [Related]
7. Targeting RAS-converting enzyme 1 overcomes senescence and improves progeria-like phenotypes of ZMPSTE24 deficiency.
Yao H; Chen X; Kashif M; Wang T; Ibrahim MX; Tüksammel E; Revêchon G; Eriksson M; Wiel C; Bergo MO
Aging Cell; 2020 Aug; 19(8):e13200. PubMed ID: 32910507
[TBL] [Abstract][Full Text] [Related]
8. The farnesyl transferase inhibitor (FTI) lonafarnib improves nuclear morphology in ZMPSTE24-deficient fibroblasts from patients with the progeroid disorder MAD-B.
Odinammadu KO; Shilagardi K; Tuminelli K; Judge DP; Gordon LB; Michaelis S
Nucleus; 2023 Dec; 14(1):2288476. PubMed ID: 38050983
[TBL] [Abstract][Full Text] [Related]
9. A humanized yeast system to analyze cleavage of prelamin A by ZMPSTE24.
Spear ED; Alford RF; Babatz TD; Wood KM; Mossberg OW; Odinammadu K; Shilagardi K; Gray JJ; Michaelis S
Methods; 2019 Mar; 157():47-55. PubMed ID: 30625386
[TBL] [Abstract][Full Text] [Related]
10. Incomplete processing of mutant lamin A in Hutchinson-Gilford progeria leads to nuclear abnormalities, which are reversed by farnesyltransferase inhibition.
Glynn MW; Glover TW
Hum Mol Genet; 2005 Oct; 14(20):2959-69. PubMed ID: 16126733
[TBL] [Abstract][Full Text] [Related]
11. Prelamin A and ZMPSTE24 in premature and physiological aging.
Worman HJ; Michaelis S
Nucleus; 2023 Dec; 14(1):2270345. PubMed ID: 37885131
[TBL] [Abstract][Full Text] [Related]
12. Human ZMPSTE24 disease mutations: residual proteolytic activity correlates with disease severity.
Barrowman J; Wiley PA; Hudon-Miller SE; Hrycyna CA; Michaelis S
Hum Mol Genet; 2012 Sep; 21(18):4084-93. PubMed ID: 22718200
[TBL] [Abstract][Full Text] [Related]
13. Blocking protein farnesylation improves nuclear shape abnormalities in keratinocytes of mice expressing the prelamin A variant in Hutchinson-Gilford progeria syndrome.
Wang Y; Ostlund C; Worman HJ
Nucleus; 2010; 1(5):432-9. PubMed ID: 21326826
[TBL] [Abstract][Full Text] [Related]
14.
Spear ED; Hsu ET; Nie L; Carpenter EP; Hrycyna CA; Michaelis S
Dis Model Mech; 2018 Jul; 11(7):. PubMed ID: 29794150
[TBL] [Abstract][Full Text] [Related]
15. Next-Generation Sequencing and Quantitative Proteomics of Hutchinson-Gilford progeria syndrome-derived cells point to a role of nucleotide metabolism in premature aging.
Mateos J; Fafián-Labora J; Morente-López M; Lesende-Rodriguez I; Monserrat L; Ódena MA; Oliveira E; de Toro J; Arufe MC
PLoS One; 2018; 13(10):e0205878. PubMed ID: 30379953
[TBL] [Abstract][Full Text] [Related]
16. Dermal fibroblasts in Hutchinson-Gilford progeria syndrome with the lamin A G608G mutation have dysmorphic nuclei and are hypersensitive to heat stress.
Paradisi M; McClintock D; Boguslavsky RL; Pedicelli C; Worman HJ; Djabali K
BMC Cell Biol; 2005 Jun; 6():27. PubMed ID: 15982412
[TBL] [Abstract][Full Text] [Related]
17. Accumulation of prelamin A induces premature aging through mTOR overactivation.
Pan X; Jiang B; Wu X; Xu H; Cao S; Bai N; Li X; Yi F; Guo Q; Guo W; Song X; Meng F; Li X; Liu Y; Cao L
FASEB J; 2020 Jun; 34(6):7905-7914. PubMed ID: 32282093
[TBL] [Abstract][Full Text] [Related]
18. Perturbation of wild-type lamin A metabolism results in a progeroid phenotype.
Candelario J; Sudhakar S; Navarro S; Reddy S; Comai L
Aging Cell; 2008 Jun; 7(3):355-67. PubMed ID: 18363904
[TBL] [Abstract][Full Text] [Related]
19. Site specificity determinants for prelamin A cleavage by the zinc metalloprotease ZMPSTE24.
Babatz TD; Spear ED; Xu W; Sun OL; Nie L; Carpenter EP; Michaelis S
J Biol Chem; 2021; 296():100165. PubMed ID: 33293369
[TBL] [Abstract][Full Text] [Related]
20. Targeting isoprenylcysteine methylation ameliorates disease in a mouse model of progeria.
Ibrahim MX; Sayin VI; Akula MK; Liu M; Fong LG; Young SG; Bergo MO
Science; 2013 Jun; 340(6138):1330-3. PubMed ID: 23686339
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
